CD48 is a key molecule of immunomodulation affecting prognosis in glioma

Zou, CY; Zhu, C; Guan, GF; Guo, Q; Liu, TQ; Shen, S; Yan, ZH; Xu, XY; Li, ZG; Chen, L; Wu, AH; Cheng, W

Wu, AH; Cheng, W (reprint author), China Med Univ, Hosp 1, Dept Neurosurg, Nanjing St 155, Shenyang 110001, Liaoning, Peoples R China.

ONCOTARGETS AND THERAPY, 2019; 12 (): 4181

Abstract

Purpose: Glioma is a refractory disease associated with immune cell infiltration, and the effectiveness of checkpoint blockade remains suboptimal. As ......

Full Text Link